Viewing Study NCT03687333


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-01-25 @ 5:09 AM
Study NCT ID: NCT03687333
Status: COMPLETED
Last Update Posted: 2022-04-13
First Post: 2018-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate Efficacy and Safety in Chinese Patients With Infantile-Onset Pompe Disease With One Year Alglucosidase Alfa Treatment
Sponsor: Genzyme, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-12-04
Start Date Type: ACTUAL
Primary Completion Date: 2020-12-30
Primary Completion Date Type: ACTUAL
Completion Date: 2020-12-30
Completion Date Type: ACTUAL
First Submit Date: 2018-09-24
First Submit QC Date: None
Study First Post Date: 2018-09-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-04-05
Last Update Post Date: 2022-04-13
Last Update Post Date Type: ACTUAL